Yin-xiong Li

1.2k total citations · 1 hit paper
14 papers, 969 citations indexed

About

Yin-xiong Li is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Yin-xiong Li has authored 14 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Yin-xiong Li's work include Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yin-xiong Li is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yin-xiong Li collaborates with scholars based in China, United States and Brazil. Yin-xiong Li's co-authors include Sanjay Bhanot, Anna Mae Diehl, Brett P. Monia, Shannon J. McCall, Kanji Yamaguchi, Xing Yu, Liu Yang, Jiawen Huang, Sanjay Pandey and Sanjay K. Pandey and has published in prestigious journals such as PLoS ONE, Hepatology and Archives of Biochemistry and Biophysics.

In The Last Decade

Yin-xiong Li

14 papers receiving 957 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

2007 805 citations Kanji Yamaguchi, Liu Yang et al. Hepatology profile →

Peers

Countries citing papers authored by Yin-xiong Li

Since Specialization

Citations

This map shows the geographic impact of Yin-xiong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin-xiong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin-xiong Li more than expected).

Fields of papers citing papers by Yin-xiong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin-xiong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin-xiong Li. The network helps show where Yin-xiong Li may publish in the future.

Co-authorship network of co-authors of Yin-xiong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yin-xiong Li. A scholar is included among the top collaborators of Yin-xiong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin-xiong Li. Yin-xiong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Hepatic DKK1-driven steatosis is CD36 dependent 2022 ·Life Science Alliance ·(unknown), Xinping Huang, (unknown), Kai You, Yue Xiong, Ji Fang, Anteneh Getachew, Ziqi Cheng, Xiaorui Yu, Yan Wang, (unknown), Ning Wang, (unknown), Xian-Hua Lin, Fan Yang, Yan Chen, Hongcheng Wei, Yin-xiong Li	8
2	Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin 2022 ·Cells ·Ziqi Cheng, Dongsheng Guo, (unknown), (unknown), Kai You, Yan Chen, Xinping Huang, (unknown), Fan Yang, Lizhi Niu, Kecheng Xu, Yin-xiong Li	2
3	Calcitriol alleviates ethanol-induced hepatotoxicity via AMPK/mTOR-mediated autophagy 2020 ·Archives of Biochemistry and Biophysics ·Yuan Fang, Yingying Xu, Kai You, (unknown), Fan Yang, Yin-xiong Li	24
4	Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression 2018 ·Stem Cell Research ·Yanli Liu, (unknown), (unknown), (unknown), Nasir Abbas, (unknown), (unknown), Haiyun Wang, (unknown), Dongsheng Guo, Yan Chen, (unknown), (unknown), (unknown), Fan Yang, Keyu Lai, Xiaodong Shu, Yin-xiong Li	1
5	Construction of a GLI3 compound heterozygous knockout human embryonic stem cell line WAe001-A-20 by CRISPR/Cas9 editing 2018 ·Stem Cell Research ·(unknown), Yuan Fang, (unknown), Yanli Liu, Kai You, (unknown), Yan Chen, Anteneh Getachew, Ning Wang, Yingying Xu, (unknown), Fan Yang, Yin-xiong Li	2
6	Generation of a GDE heterozygous mutation human embryonic stem cell line WAe001-A-14 by CRISPR/Cas9 editing 2017 ·Stem Cell Research ·Guosheng Xu, Dongsheng Guo, (unknown), Nasir Abbas, Keyu Lai, Yuan Fang, Kai You, Yanli Liu, (unknown), (unknown), Yingying Xu, Yan Chen, Fan Yang, (unknown), Yin-xiong Li	1
7	Generation of an ASGR1 homozygous mutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9 2017 ·Stem Cell Research ·Yingying Xu, (unknown), Dongsheng Guo, Ge Gao, Keyu Lai, Fan Yang, Kepin Wang, Han Wu, Liangxue Lai, Jialiang Li, Kecheng Xu, Yin-xiong Li	2
8	Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing 2017 ·Stem Cell Research ·(unknown), Ge Gao, (unknown), Zhen Yang, Guosheng Xu, Nasir Abbas, Yanli Liu, Yan Chen, (unknown), Kai You, (unknown), (unknown), Xian-Hua Lin, Fan Yang, Yin-xiong Li	2
9	Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells 2017 ·PLoS ONE ·Hai‐Kun Liu, Dongsheng Guo, (unknown), Yan Chen, (unknown), Fan Yang, Jialiang Li, Kecheng Xu, Tiancheng Zhou, Dajiang Qin, Yin-xiong Li	13
10	Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9 2017 ·Stem Cell Research ·Yuan Fang, Dongsheng Guo, Yanli Liu, Yingying Xu, Ge Gao, (unknown), Fan Yang, (unknown), Keyu Lai, Hongcheng Wei, Yin-xiong Li	2
11	Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9 2017 ·Stem Cell Research ·Yuan Fang, Dongsheng Guo, Ge Gao, Yanli Liu, Yingying Xu, (unknown), Fan Yang, (unknown), Keyu Lai, Liangqing Hong, Yin-xiong Li	7
12	Self-Organizing Tissue-Engineered Constructs in Collagen Hydrogels 2012 ·Microscopy and Microanalysis ·Robert G. Gourdie, Tereance A. Myers, (unknown), Yin-xiong Li, Jay D. Potts	10
13	Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis breakdown → 2007 ·Hepatology ·Kanji Yamaguchi, Liu Yang, Shannon J. McCall, Jiawen Huang, Xing Yu, Sanjay Pandey, Sanjay Bhanot, Brett P. Monia, Yin-xiong Li, Anna Mae Diehl	805
14	Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis 2007 ·Hepatology ·Kanji Yamaguchi, Liu Yang, Shannon J. McCall, Jiawen Huang, Xing Yu, Sanjay K. Pandey, Sanjay Bhanot, Brett P. Monia, Yin-xiong Li, Anna Mae Diehl	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact